A recent study reveals a significant shift in vaccine administration for toddlers that increases their risk of febrile seizures. The analysis shows a move away from the preferred MMR+V vaccine toward the MMRV combination shot for children aged 12 to 15 months.
Data indicates MMRV carries a higher seizure risk for first doses. Studies found 7 to 8.5 seizure cases per 10,000 MMRV vaccinations, compared to 3.2 to 4.2 cases per 10,000 for separate MMR+V shots. This translates to approximately one additional febrile seizure per 2,300 to 2,600 children. While generally harmless and without long-term effects, these seizures are alarming for parents.
Following this risk assessment in 2009, the Advisory Committee on Immunization Practices (ACIP) recommended MMR+V as the preferred option. MMRV remained an approved and available choice for use in consultation with doctors. No new data has altered this expert consensus.
In King County, Washington, between 2015 and 2025, 15% of vaccinated children received MMRV as their first dose. This group showed clear demographic trends. Children receiving MMRV were significantly more likely to be from minority racial and ethnic groups. They were also more than three times as likely to be eligible for the federal Vaccines for Children program and nearly four times more likely to be vaccinated at a safety-net clinic. A large portion received their dose as a 'catch-up' vaccination outside the standard 12-to-15-month window.